Drawing for BIVICTRIX

USPTO serial 79345166

BIVICTRIX

Reviewed by CopyMark Law Group

Reg. 7894914Status 700Registered
Filing date
Status date
Registration date
Aug 19, 2025
Examiner
KOVALSKY, LAURA G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIVICTRIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leon R. Legleiter

Leon R. Legleiter KDW Firm PLLC2601 Weston Parkway, Suite 103Cary, NC 27513United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, preparations for the treatment of cancer; medical preparations, namely, preparations for the treatment of cancer; veterinary preparations, namely, preparations for the treatment of cancer; anti-cancer drugs; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; biological preparations for medical purposes, namely, for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of cancer; biotechnological preparations for medical use for the treatment of cancer; chemical preparations for medical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical use, namely, for prevention or treatment of cancer; chemotherapeutics; pharmaceutical compounds for treating cancer; drugs for medical purposes for the treatment of cancer; medicines, namely, medicines for cancer disorders; medicines for human purposes, namely, cancer medicines; pharmaceutical compositions, namely, preparations for the treatment of cancer; pharmaceutical drugs, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, preparations for the treatment of cancer; pharmaceutical preparations for medical purposes, namely, preparations for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 12, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 25, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 25, 2026FIMPFINAL DISPOSITION PROCESSED—
Nov 19, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 19, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 19, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 3, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 3, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 28, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 30, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 30, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Apr 30, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 30, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 30, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 28, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 28, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 30, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 30, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 30, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 2, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 7, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 20, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 20, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 2, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 2, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Oct 2, 2023CNSLSUSPENSION LETTER WRITTEN—
Aug 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 15, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 15, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2023RFNTREFUSAL PROCESSED BY IB—
Feb 15, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 15, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 20, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 19, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2022DOCKASSIGNED TO EXAMINER—
Jul 19, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 15, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 14, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance